These discoveries not only offer a new perspective for understanding the molecular mechanisms of LNM in HNSCC but also establish a theoretical foundation for the development of potential therapeutic strategies targeting SLC7A2 and CPB2. This evidence concerns the gene SLC7A2 and head and neck squamous cell carcinoma.